A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer
Open Access
- 26 December 2006
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 3 (12) , e467
- https://doi.org/10.1371/journal.pmed.0030467
Abstract
Lung cancer is the leading cause of cancer-related death in the United States. Nearly 50% of patients with stages I and II non-small cell lung cancer (NSCLC) will die from recurrent disease despite surgical resection. No reliable clinical or molecular predictors are currently available for identifying those at high risk for developing recurrent disease. As a consequence, it is not possible to select those high-risk patients for more aggressive therapies and assign less aggressive treatments to patients at low risk for recurrence. In this study, we applied a meta-analysis of datasets from seven different microarray studies on NSCLC for differentially expressed genes related to survival time (under 2 y and over 5 y). A consensus set of 4,905 genes from these studies was selected, and systematic bias adjustment in the datasets was performed by distance-weighted discrimination (DWD). We identified a gene expression signature consisting of 64 genes that is highly predictive of which stage I lung cancer patients may benefit from more aggressive therapy. Kaplan-Meier analysis of the overall survival of stage I NSCLC patients with the 64-gene expression signature demonstrated that the high- and low-risk groups are significantly different in their overall survival. Of the 64 genes, 11 are related to cancer metastasis (APC, CDH8, IL8RB, LY6D, PCDHGA12, DSP, NID, ENPP2, CCR2, CASP8, and CASP10) and eight are involved in apoptosis (CASP8, CASP10, PIK3R1, BCL2, SON, INHA, PSEN1, and BIK). Our results indicate that gene expression signatures from several datasets can be reconciled. The resulting signature is useful in predicting survival of stage I NSCLC and might be useful in informing treatment decisions.Keywords
This publication has 52 references indexed in Scilit:
- One Hundred Years of Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2005
- New therapeutic approaches for early stage non-small cell lung cancerSurgical Oncology, 2005
- Molecular Signatures in Biopsy Specimens of Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung?Molecular Cancer, 2004
- Summaries of Affymetrix GeneChip probe level dataNucleic Acids Research, 2003
- Screening for Lung Cancer*Chest, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.2002
- Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesProceedings of the National Academy of Sciences, 2001
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997